Header Logo

Connection

Michael O'Dwyer to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Michael O'Dwyer has written about Antibodies, Monoclonal, Humanized.
Michael O'Dwyer
Connection Strength
0.224
Antibodies, Monoclonal, Humanized
  1. Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity. Int Immunopharmacol. 2026 Apr 15; 175:116222.
    View in: PubMed
    Score: 0.224
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.